EU watchdog approves 10 new drugs
Article written by Gary Finnegan. The European Medicines Agency (EMA) has given the green light for ten new medicines at the latest meeting of its influential Committee for… read more.
Article written by Gary Finnegan. The European Medicines Agency (EMA) has given the green light for ten new medicines at the latest meeting of its influential Committee for… read more.
Interview and article by Christine Clark Pharmacist Anita Hogg explains how well Medicines Optimisation Innovation Centre (MOIC) model to estimate the critical care drug requirements during the covid-19… read more.
Interview and article by Christine Clark Pharmacist Anita Hogg explains how the Medicines Optimisation Innovation Centre (MOIC) in Belfast developed and applied a model to estimate the critical… read more.
Interview and article by Christine Clark Pharmacist Anita Hogg explains the work of the Medicines Optimisation Innovation Centre (MOIC) in Belfast and how the Centre helped to ensure… read more.
Research undertaken by RCSI University of Medicine and Health Sciences suggests that integrating pharmacists into general practice (GP) teams facilitates collaboration to optimise treatment plans for patients with… read more.
Interview and article by Christine Clark Practice pharmacists were able to adjust and simplify drug treatment to ensure continued effective treatment during the covid pandemic – and could… read more.
Interview and article by Christine Clark Two programmes comprising training materials and back-up resources, have been essential for the development of effective practice pharmacy services that deliver meaningful… read more.
Interview and article by Christine Clark. Pro-active case-finding to optimise treatment of long-term conditions is one the tasks undertaken by pharmacists working in GP practices. Shailen Rao, whose… read more.
Article written by Christine Clark Flu vaccination is safe, effective and is offered free of charge to thirty million people in the UK this year in the country’s… read more.
Article written by Peter Mas-Mollinedo With the outbreak of the Pandemic and the lingering worries of COVID-19 pharmaceutical sales and marketing has taken a hit. There are no… read more.
AstraZeneca announced high-level results from Farxiga’s (dapagliflozin) Phase III DAPA-CKD trial showed a statistically significant and clinically meaningful effect on its primary endpoint of a composite of worsening… read more.
Pfizer Inc. and BioNTech SE announced the start of a global (except for China) Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.